Skip to content

Twist Bioscience Corporation TWST Other Noncash Income (Expense)

Other Noncash Income (Expense) at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
-$21M-320%
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
Agilent Technologies logo
Agilent TechnologiesA
Illumina logo
IlluminaILMN
AbbVie logo
AbbVieABBV

Other financials

Income statement

See full
Revenue$110.7M+19.3%
Gross profit$57.1M+24.1%
Operating income-$45.9M-10.4%
Net income-$44.0M-11.9%
EPS (diluted)-$0.71-7.6%

Balance sheet

See full
Cash & equivalents$124.9M-41.4%
Total debt$110.8M+16.3%
Total equity$455.1M+3.4%
Total assets$676.2M+13.5%

Cash flow

See full
Operating cash flow-$17.6M-35.2%
CapEx$7.9M+90.3%
Free cash flow-$25.4M-48.5%

Valuation

See full
Market cap$5.45B+24.4%
Enterprise value$5.44B+30.4%
P/S13.3×+0.7×

Profitability

See full
Gross margin52.1%+5.4pp
Operating margin-33.9%-9.9pp
Net margin-19.8%-7.7pp
FCF margin-23.2%+7.0pp

Returns & leverage

See full
Return on equity-18.2%-6.3pp
Debt / equity0.2×0.0×
Current ratio2.7×-1.8×

Where this comes from

Reported directly by Twist Bioscience Corporation in its filing.

Tagged under the XBRL concept us-gaap:OtherNoncashIncomeExpense.

The official record: Twist Bioscience Corporation’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Twist Bioscience Corporation's other noncash income (expense).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Twist Bioscience Corporation's other noncash income (expense)?
Twist Bioscience Corporation (TWST) reported other noncash income (expense) of $498K in Q1 2026.
How has Twist Bioscience Corporation's other noncash income (expense) changed year-over-year?
Twist Bioscience Corporation's other noncash income (expense) increased by 159.9% year-over-year, from -$831K to $498K.
What does other noncash income (expense) mean?
This captures miscellaneous non-cash adjustments to net income that do not fit into standard categories like depreciation or stock-based compensation. It includes items such as changes in fair value of certain liabilities or non-cash impairment charges.